Milrinone for persistent pulmonary hypertension of the newborn

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Bassler, Dirk ^a   Kreutzer, Karen ^a   McNamara, Patrick ^b   Kirpalani, Haresh ^c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c MCMASTER CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT; MILRINONE; NITRIC OXIDE; OXYGEN; PLACEBO; VASODILATOR AGENT;

BLINDNESS; BRAIN HEMORRHAGE; CEREBRAL PALSY; CLINICAL TRIAL; CONGENITAL DIAPHRAGM HERNIA; DISEASE SEVERITY; DRUG EFFECT; EXTRACORPOREAL OXYGENATION; HEARING IMPAIRMENT; HOSPITAL DISCHARGE; HUMAN; HYPERVENTILATION; HYPOTENSION; LUNG DYSPLASIA; NERVE CELL DIFFERENTIATION; NEWBORN; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PERSISTENT PULMONARY HYPERTENSION; POST HOC ANALYSIS; PREMATURITY; REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TERM BIRTH; TREATMENT DURATION;

EID: 70349102145     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007802     Document Type: Review

References (11)

1. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000509.pub3]
2. Bassler D, Choong K, McNamara P, et al.Neonatal persistent pulmonary hypertension treated with Milrinone: Four case reports. Biology of the Neonate 2006;89:1-5. (Pubitemid 43087502)
3. Clarke WR, Uezono S, Chambers A, et al. The type III phosphodiesterase inhibitor milrinone and type V PDE inhibitor dipyridamole individually and synergistically reduce elevated pulmonary vascular resistance. Pulmonary Pharmacology 1994;7:81-89 (Pubitemid 24210799)
4. Farrow KN, Fliman P, Steinhorn RH. The disease treated with ECMO: focus on PPHN. Seminars in Perinatology 2005;29:8-14. (Pubitemid 40488986)
5. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD000399.pub2]
6. McNamara PJ, Laique F, Muang-In S, Whyte HE. Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006;21:217-222 (Pubitemid 43850191)
7. Mugford M, Elbourne D, Field D. Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database of Systematic Reviews 2008 Jul 16, Issue 3.[Art. No.: CD001340. DOI: 10.1002/14651858. CD001340.pub2]
8. The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.. New England Journal of Medicine 1997;336:597-604.
9. Stevens DC, Schreiner RL, Bull MJ, Bryson CQ, Lemons JA, Gresham EL, Grosfeld JL, Weber TR. An analysis of tolazoline therapy in the critically-ill neonate. Journal of Pediatric Surgery 1980;15: 964-970. (Pubitemid 11217401)
10. No authors listed. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996;348:75-82. (Pubitemid 26234353)
11. Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcome. Pediatrics 2000;105:14-20.